Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Anna Schuh

Director of Molecular Diagnostics

  • Honorary Consultant Haematologist

Research Summary

The aim of our research is to identify molecular-based disease classifiers using clinical omics to underpin precision medicine approaches to be used for the selection of patients for the appropriate therapy.

Biography

Professor Schuh has participated as a principle or chief investigator in over 30 early or late phase clinical trials in chronic lymphocytic leukaemia. A number of these led to subsequent NICE approvals and have changed clinical practice in the UK and worldwide. As the Director of the Oxford NIHR Molecular Diagnostics Centre (MDC), she receives grants from the NIHR, Wellcome Trust, Technology Strategy Board and Bloodwise.

Her primary research interest is with the development, evaluation and implementation of new technologies for precision diagnostics with a particular focus on genomics. She leads the Genomics England Clinical Interpretation Partnership for Haematological Malignancies on behalf of the NCRN clinical investigators and has authored or co-authored over 80 peer-reviewed publications in the last five years.

GROUP MEMBERS

Niamh Appleby, Health Education England/ Genomics England Genomic Medicine Fellow
David Bruce, Clinical Research Fellow
Adam Burns, Post-doctoral Researcher
Dr Anthony Cutts, Postdoctoral Researcher
Helene Dreau, MSc. Principal Clinical Scientist / Head of the NGS Core Facilities (Clinical).
Jenny Klintman, MD PhD, Visiting Post-doctoral fellow
Laura del Carmen Lopez Pascua, Clinical Scientist with Bioinformatics
Kate Ridout, High-throughput Sequencing Bioinformatician
Dimitrios V. Vavoulis, High-throughput Bioinformatician